Why the study?
Does omega-3 fatty acid supplementation reduce platelet aggregability and thromboxane B2 concentration in healthy mildly overweight men?
Does omega-3 fatty acid supplementation reduce platelet aggregability and thromboxane B2 concentration in healthy mildly overweight men?
A 12-week supplementation of omega-3 fatty acids does not have a sustained effect on ADP-induced platelet aggregation or thromboxane production in healthy mildly overweight men.
Answers are grounded in this paper and cite their sources.
Omega-3 supplementation should not be expected to inhibit platelet function in mildly overweight men; challenges antiplatelet mechanism hypotheses and redirects mechanistic research.
We investigated the sustained effect of 12-week supplementation of 2.880 g/day of omega-3 fatty acids on platelet aggregability, platelet produced thromboxane B2 concentration and serum fatty acid composition in a double-blind controlled trial in 44 healthy mildly overweight eastern Finnish men recruited from a representative population sample. The supplementation was discontinued seven days before the biochemical measurements. Body weight, alcohol consumption and dietary composition remained constant during the study. Even though the percentage of eicosapentaenoic acid (20:5 omega 3) in total serum lipids increased by 37% (p less than 0.01) and that of dihomo-gamma-linolenic acid (20:3 omega 6) decreased by 18% (p less than 0.01) more in the omega-3 supplemented than placebo group during supplementation, there were no significant differences in the changes in either the ADP induced platelet aggregation or in vitro platelet produced thromboxane B2 concentration between the groups. These data suggest that omega-3 fatty acids have no detectable sustained effect either on ADP induced platelet aggregation or on thromboxane produced by the platelets in vitro.
No takes yet. Share an insight, caveat, or question.
Salonen et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: